ArticleBMC pulmonary medicine2020

A phase Ib/IIa, randomised, double-blind, multicentre trial to assess the safety and efficacy of expanded Cx611 allogeneic adipose-derived stem cells (eASCs) for the treatment of patients with community-acquired bacterial pneumonia admitted to the intensive care unit.

Pierre-François Laterre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.